Anti-Inflammatory Activity of Immunoglobulin G Resulting from Fc Sialylation
The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Abstract
Immunoglobulin G (IgG) mediates pro- and anti-inflammatory activities through the engagement of its Fc fragment (Fc) with distinct Fcg receptors (FcgRs). One class of Fc-FcgR interactions generates pro-inflammatory effects of immune complexes and cytotoxic antibodies. In contrast, therapeutic intravenous gamma globulin and its Fc fragments are anti-inflammatory. We show here that these distinct properties of the IgG Fc result from differential sialylation of the Fc core polysaccharide. IgG acquires anti-inflammatory properties upon Fc sialylation, which is reduced upon the induction of an antigen-specific immune response. This differential sialylation may provide a switch from innate anti-inflammatory activity in the steady state to generating adaptive pro-inflammatory effects upon antigenic challenge.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“CREB activation can promote the expression of anti-inflammatory genes while inhibiting inflammatory genes.294,295”
From Glucagon-like peptide-1 receptor: mechanisms and advances in therapy (2024) · cites this paper as [295]
Citations
Cites
Shields, R. L., Lai, J., Keck, R., O'Connell, L. Y., Hong, K., Meng, Y. G., Weikert, S. H. A., & Presta, L. G. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202069200 · Cited by 1,835
HIGH-DOSE INTRAVENOUS GAMMAGLOBULIN FOR IDIOPATHIC THROMBOCYTOPENIC PURPURA IN CHILDHOOD
Imbach, P., d'APUZZO, V., Hirt, A., Rossi, E., Vest, M., Barandun, S., Baumgartner, C., Morell, A., Schöni, M., & Wagner, H. P. (1981) · The Lancet · doi:10.1016/s0140-6736(81)92400-4 · Cited by 1,666
Parekh, R. B., Dwek, R. A., Sutton, B. J., Fernandes, D. L., Leung, A., Stanworth, D., Rademacher, T. W., Mizuochi, T., Taniguchi, T., Matsuta, K., et al. (1985) · Nature · doi:10.1038/316452a0 · Cited by 1,170
Fcγ Receptors: Old Friends and New Family Members
Nimmerjahn, F., & Ravetch, J. V. (2006) · Immunity · doi:10.1016/j.immuni.2005.11.010 · Cited by 1,072
Self-citationAnti-inflammatory Activity of IVIG Mediated Through the Inhibitory Fc Receptor
Samuelsson, A., Towers, T. L., & Ravetch, J. V. (2001) · Science · doi:10.1126/science.291.5503.484 · Cited by 1,053
Self-citationDivergent Immunoglobulin G Subclass Activity Through Selective Fc Receptor Binding
Nimmerjahn, F., & Ravetch, J. V. (2005) · Science · doi:10.1126/science.1118948 · Cited by 1,037
Self-citationArthritis Critically Dependent on Innate Immune System Players
Ji, H., Ohmura, K., Mahmood, U., Lee, D. M., Hofhuis, F. M. A., Boackle, S. A., Takahashi, K., Holers, V. M., Walport, M., Gerard, C., et al. (2002) · Immunity · doi:10.1016/s1074-7613(02)00275-3 · Cited by 693
FcγRIV: A Novel FcR with Distinct IgG Subclass Specificity
Nimmerjahn, F., Bruhns, P., Horiuchi, K., & Ravetch, J. V. (2005) · Immunity · doi:10.1016/j.immuni.2005.05.010 · Cited by 660
Self-citationManipulating the Immune System with Immune Globulin
Oates, J. A., Wood, A. J. J., & Dwyer, J. M. (1992) · New England Journal of Medicine · doi:10.1056/nejm199201093260206 · Cited by 648
Effect of glycosylation on antibody function: implications for genetic engineering
Wright, A., & Morrison, S. L. (1997) · Trends in Biotechnology · doi:10.1016/s0167-7799(96)10062-7 · Cited by 312
Research works printed but not linked: 1
- M. Holland et al., Biochim. Biophys. Acta1760, 669 (2005).
Cited by
Items 701–800 of 1,003
Innate Humoral Defense Factors
Hajishengallis, G., & Russell, M. W. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-415847-4.00015-x · Cited by 47
Tsai, C., Li, K., Shen, C., Lu, C., Lee, H.-T., Wu, T.-H., Ng, Y., Tsao, Y., Hsieh, S., & Yu, C. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241210066 · Cited by 38
Immunoglobulin G N-glycan markers of accelerated biological aging during chronic HIV infection
Giron, L. B., Liu, Q., Adeniji, O. S., Yin, X., Kannan, T., Ding, J., Lu, D. Y., Langan, S. J., Zhang, J., Azevedo, J. L. L. C., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-47279-4 · Cited by 38
Intravenous Immunoglobulins in Autoimmune and Inflammatory Diseases: A Mechanistic Perspective
Sibéril, S., Elluru, S. R., Graff‐Dubois, S., Negi, V.-S., Delignat, S., Mouthon, L., Lacroix‐Desmazes, S., Kazatchkine, M. D., Bayry, J., & Kaveri, S. V. (2007) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1423.052 · Cited by 35
Scallon, B. J., McCarthy, S. G., Radewonuk, J., Cai, A., Naso, M. F., Raju, T. S., & Capocasale, R. J. (2007) · International Immunopharmacology · doi:10.1016/j.intimp.2007.01.014 · Cited by 35
Harmon, E. Y., Fronhofer, V., Keller, R. S., Feustel, P. J., Zhu, X., Xu, H., Avram, D., Jones, D., Nagarajan, S., & Lennartz, M. R. (2014) · Journal of the American Heart Association · doi:10.1161/jaha.114.001232 · Cited by 38
The pathogenic potential of autoreactive antibodies in rheumatoid arthritis
Bax, M., Huizinga, T. W. J., & Toes, R. E. M. (2014) · Seminars in Immunopathology · doi:10.1007/s00281-014-0429-5 · Cited by 40
Therapeutic Potential of Intravenous Immunoglobulin in Acute Brain Injury
Häußler, V., Arumugam, T. V., Magnus, T. U., & Gelderblom, M. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00875 · Cited by 38
Glycans as critical regulators of gut immunity in homeostasis and disease
Dias, A. M., Pereira, M. S., Padrão, N., Alves, I., Marcos‐Pinto, R., Lago, P., & Pinho, S. S. (2018) · Cellular Immunology · doi:10.1016/j.cellimm.2018.07.007 · Cited by 38
Sialylated Immunoglobulins for the Treatment of Immuno-Inflammatory Diseases
Markina, Y. V., Герасимова, Е. В., Markin, A. M., Glanz, V. Y., Wu, W., Sobenin, I. A., & Orekhov, A. N. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21155472 · Cited by 36
Humoral signatures of MOG-antibody-associated disease track with age and disease activity
Spatola, M., Chuquisana, O., Jung, W., Lopez, J. A., Wendel, E., Ramanathan, S., Keller, C. W., Hahn, T., Meinl, E., Reindl, M., et al. (2023) · Cell Reports Medicine · doi:10.1016/j.xcrm.2022.100913 · Cited by 41
Sialylation Determines the Nephritogenicity of IgG3 Cryoglobulins
Otani, M., Kuroki, A., Kikuchi, S., Kihara, M., Nakata, J., Ito, K., Furukawa, J., Shinohara, Y., & Izui, S. (2012) · Journal of the American Society of Nephrology · doi:10.1681/asn.2012050477 · Cited by 37
The role of genetics and antibodies in sepsis
Giamarellos‐Bourboulis, E. J., & Opal, S. M. (2016) · Annals of Translational Medicine · doi:10.21037/atm.2016.08.63 · Cited by 34
Glycosylation profiles determine extravasation and disease-targeting properties of armed antibodies
Venetz, D., Hess, C., Lin, C., Aebi, M., & Neri, D. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1416694112 · Cited by 36
Jiang, K., Zhu, H., Li, L., Guo, Y., Gashash, E. A., Ma, C., Sun, X., Li, J., Zhang, L., & Wang, P. G. (2017) · Analytica Chimica Acta · doi:10.1016/j.aca.2017.05.029 · Cited by 36
Ząbczyńska, M., Polak, K., Kozłowska, K., Sokołowski, G., & Pocheć, E. (2020) · Biomolecules · doi:10.3390/biom10020171 · Cited by 39
Association of the IgG N -glycome with the course of kidney function in type 2 diabetes
Singh, S. S., Heijmans, R., der Meulen, C. C. M. V. C.-V., Lieverse, A. G., Gornik, O., Sijbrands, E. J. G., Lauc, G., & van Hoek, M. (2020) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2019-001026 · Cited by 40
Association of dementia with immunoglobulin G N-glycans in a Chinese Han Population
Zhang, X., Yuan, H., Lyu, J., Meng, X., Tian, Q., Li, Y., Zhang, J., Xu, X., Su, J., Hou, H., et al. (2021) · npj Aging and Mechanisms of Disease · doi:10.1038/s41514-021-00055-w · Cited by 40
Klehmet, J., Göhler, J., Ulm, L., Köhler, S., Meisel, C., Meisel, A., & Harms, H. (2014) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2014-307708 · Cited by 33
Antibody-Based Therapy in Colorectal Cancer
Noguchi, T., Ritter, G., & Nishikawa, H. (2013) · Immunotherapy · doi:10.2217/imt.13.35 · Cited by 34
Antibodies in breast milk: Pro‐bodies designed for healthy newborn development
Verhasselt, V., Tellier, J., Carsetti, R., & Tepekule, B. (2024) · Immunological Reviews · doi:10.1111/imr.13411 · Cited by 41
Saenger, Y. M., Li, Y., Chiou, K. C., Chan, B., Rizzuto, G. A., Terzulli, S. L., Merghoub, T., Houghton, A. N., & Wolchok, J. D. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-2233 · Cited by 40
Therapeutic Use of Immunoglobulins
Stiehm, E. R., Orange, J. S., Ballow, M. C., & Lehman, H. K. (2010) · Advances in Pediatrics · doi:10.1016/j.yapd.2010.08.005 · Cited by 32
Zhong, X., Cooley, C., Seth, N. P., Juo, Z. S., Presman, E., Resendes, N., Kumar, R. A., Allen, M., Mosyak, L., Stahl, M., et al. (2012) · Biotechnology and Bioengineering · doi:10.1002/bit.24448 · Cited by 34
Chemoenzymatic Glyco-engineering of Monoclonal Antibodies
Giddens, J. P., & Wang, L. (2015) · Methods in molecular biology · doi:10.1007/978-1-4939-2760-9_25 · Cited by 32
Bertók, T., Šedivá, A., Filip, J., Ilčíková, M., Kasák, P., Velič, D., Jáné, E., Mravcová, M., Rovenský, J., Kunzo, P., et al. (2015) · Langmuir · doi:10.1021/acs.langmuir.5b00944 · Cited by 33
New Insights into Pericarditis: Mechanisms of Injury and Therapeutic Targets
Xu, B., Harb, S. C., & Cremer, P. C. (2017) · Current Cardiology Reports · doi:10.1007/s11886-017-0866-6 · Cited by 33
New insights into IVIg mechanisms and alternatives in autoimmune and inflammatory diseases
Norris, P. A. A., Kaur, G., & Lazarus, A. H. (2020) · Current Opinion in Hematology · doi:10.1097/moh.0000000000000609 · Cited by 40
Rossignol, D. A., & Frye, R. E. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11060488 · Cited by 42
Miranda, L. R., Duval, M., Doherty, H., Seaman, M. S., Posner, M. R., & Cavacini, L. A. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.11.7132 · Cited by 35
Intramolecular Glycan–Protein Interactions in Glycoproteins
Barb, A. W., Borgert, A. J., Liu, M., Bárány, G., & Live, D. H. (2010) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(10)78018-6 · Cited by 35
Dall’Olio, F. (2018) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-981-13-2835-0_17 · Cited by 35
Polyclonal intravenous immunoglobulin: An important additional strategy in sepsis?
Rosa, R. D., Pietrosanti, M., Luzi, G., Salemi, S., & D’Amelio, R. (2014) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2014.05.002 · Cited by 32
Sugar‐free Antibodies—The Bacterial Solution to Autoimmunity?
Allhorn, M., & Collin, M. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.04739.x · Cited by 31
Okbazghi, S. Z., More, A. S., White, D. R., Duan, S., Shah, I. S., Joshi, S. B., Middaugh, C. R., Volkin, D. B., & Tolbert, T. J. (2016) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2015.11.003 · Cited by 36
Liu, H., Nowak, C., Andrien, B. A., Shao, M., Ponniah, G., & Neill, A. (2017) · Biotechnology Progress · doi:10.1002/btpr.2498 · Cited by 35
Antibody and antibody derivatives as cancer therapeutics
Arlotta, K. J., & Owen, S. C. (2019) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1556 · Cited by 35
Glycosylation-dependent opsonophagocytic activity of staphylococcal protein A antibodies
Chen, X., Shi, M., Tong, X., Kim, H. K., Wang, L., Schneewind, O., & Missiakas, D. M. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2003621117 · Cited by 33
Sweet and Sour: The Role of Glycosylation for the Anti-inflammatory Activity of Immunoglobulin G
Böhm, S., Kao, D., & Nimmerjahn, F. (2014) · Current topics in microbiology and immunology · doi:10.1007/978-3-319-07911-0_18 · Cited by 32
Self-citationKlein, A. (2008) · PubMed · Cited by 33
Zhong, X., Jagarlapudi, S., Weng, Y., Ly, M., Rouse, J. C., McClure, K. F., Ishino, T., Zhang, Y., Sousa, E. A., Cohen, J. D., et al. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.012144 · Cited by 31
Teuton, J., & Brandt, C. R. (2007) · Journal of Virology · doi:10.1128/jvi.02250-06 · Cited by 31
Prater, B. D., Anumula, K. R., & Hutchins, J. T. (2007) · Analytical Biochemistry · doi:10.1016/j.ab.2007.07.011 · Cited by 31
Immune Complex Pathophysiology
NYDEGGER, U. E. (2007) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1398.009 · Cited by 31
The role of glycosylation in clinical allergy and immunology
Hale, R. C., Morais, D., Chou, J. S., & Stowell, S. R. (2023) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2023.09.003 · Cited by 31
IgG4 can induce an M2-like phenotype in human monocyte-derived macrophages through FcγRI
Swisher, J. F. A., Haddad, D. A., McGrath, A. G., Boekhoudt, G. H., & Feldman, G. M. (2014) · mAbs · doi:10.4161/19420862.2014.975657 · Cited by 31
Wang, H., Li, X., Wang, X., Liu, D., Zhang, X., Cao, W., Zheng, Y., Guo, Z., Li, D., Xing, W., et al. (2019) · OMICS A Journal of Integrative Biology · doi:10.1089/omi.2019.0099 · Cited by 35
Komaromy, A., Reider, B., Járvás, G., & Guttman, A. (2020) · Clinica Chimica Acta · doi:10.1016/j.cca.2020.03.041 · Cited by 33
Granel, J., Korkmaz, B., Nouar, D., Weiß, S. A. I., Jenne, D. E., Lemoine, R., & Hoarau, C. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.571933 · Cited by 32
Fc Receptors in Immune Responses
Mancardi, D. A., & Daëron, M. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.00119-7 · Cited by 41
Zhao, J., Liu, J., Liu, X., Cao, Q., Zhao, H., Liu, L., Ye, F., Wang, C., Shao, H., Xue, D., et al. (2022) · Chinese Journal of Chemistry · doi:10.1002/cjoc.202100914 · Cited by 30
Mimura, Y., Mimura‐Kimura, Y., Saldova, R., Rudd, P. M., & Jefferis, R. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.818382 · Cited by 35
Immunoassay for quantification of antigen-specific IgG fucosylation
Šuštić, T., Coillie, J. V., Larsen, M. D., Derksen, N. I. L., Szittner, Z., Nouta, J., Wang, W., Damelang, T., Rebergen, I., Linty, F., et al. (2022) · EBioMedicine · doi:10.1016/j.ebiom.2022.104109 · Cited by 32
Targeting the complexity of ERBB2 biology in gastroesophageal carcinoma
Augustin, J., Soussan, P., & Bass, A. J. (2022) · Annals of Oncology · doi:10.1016/j.annonc.2022.08.001 · Cited by 37
Ripellino, P., Fleetwood, T., Cantello, R. M., & Comi, C. (2014) · Autoimmune Diseases · doi:10.1155/2014/201657 · Cited by 30
Shinzaki, S., Iijima, H., Fujii, H., Kuroki, E., Tatsunaka, N., Inoue, T., Nakajima, S., Egawa, S., Kanto, T., Tsujii, M., et al. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.02.008 · Cited by 30
Intravenous Immunoglobulin and Immunomodulation of B-Cell – in vitro and in vivo Effects
Mitrevski, M., Marrapodi, R., Camponeschi, A., Cavaliere, F. M., Lazzeri, C., Todi, L., & Visentini, M. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00004 · Cited by 30
Fab fragment glycosylated IgG may play a central role in placental immune evasion
Gu, J., Yu, L., Huang, Y., Zhao, Y., Li, J., Huang, T., Zhang, J., Wang, J., Deng, X., Chen, Z., et al. (2014) · Human Reproduction · doi:10.1093/humrep/deu323 · Cited by 35
N-Glycosylation of Serum IgG and Total Glycoproteins in MAN1B1 Deficiency
Saldova, R., Stöckmann, H., O’Flaherty, R., Lefeber, D. J., Jaeken, J., & Rudd, P. M. (2015) · Journal of Proteome Research · doi:10.1021/acs.jproteome.5b00709 · Cited by 30
Stümer, J., Biermann, M. H. C., Knopf, J., Magorivska, I., Kastbom, A., Svärd, A., Janko, C., Bilyy, R. O., Schett, G. A., Sjöwall, C., et al. (2017) · Clinical & Experimental Immunology · doi:10.1111/cei.12987 · Cited by 30
Schaffert, A., Hanić, M., Novokmet, M., Zaytseva, O. O., Krištić, J., Lux, A., Nitschke, L., Peipp, M., Pezer, M., Hennig, R., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2019.03024 · Cited by 28
Self-citationImmunomodulatory and anti‐inflammatory properties of immunoglobulin G antibodies
Hematianlarki, M., & Nimmerjahn, F. (2024) · Immunological Reviews · doi:10.1111/imr.13404 · Cited by 32
Self-citationAntibody-Mediated Rejection—An Ounce of Prevention Is Worth a Pound of Cure
Bradley, J. A., Baldwin, W. M., Bingaman, A. W., Ellenrieder, C., Gebel, H. M., Glotz, D., & Kirk, A. D. (2011) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2011.03581.x · Cited by 29
Zhang, P., Chan, K. F., Haryadi, R., Bardor, M., & Song, Z. (2012) · Advances in biochemical engineering, biotechnology · doi:10.1007/10_2012_163 · Cited by 33
Acute inflammation primes myeloid effector cells for anti-inflammatory STAT6 signaling
Wermeling, F., Anthony, R. M., Brombacher, F., & Ravetch, J. V. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1312525110 · Cited by 29
Self-citationSvetlicky, N., Ortega‐Hernandez, O., Mouthon, L., Guillevin, L., Thiesen, H., Altman, A., Kravitz, M. S., Blank, M., & Shoenfeld, Y. (2012) · Journal of Clinical Immunology · doi:10.1007/s10875-012-9842-5 · Cited by 29
Therapeutic antibodies as a treatment option for dengue fever
Chan, K. R., Ong, E. Z., & Ooi, E. E. (2013) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.2013.839941 · Cited by 31
Cheng, H. D., Stöckmann, H., Adamczyk, B., McManus, C. A., Ercan, A., Holm, I. A., Rudd, P. M., Ackerman, M. E., & Nigrovic, P. A. (2017) · Glycobiology · doi:10.1093/glycob/cwx082 · Cited by 30
Immune modulation of i.v. immunoglobulin in women with reproductive failure
Han, A. R., & Lee, S. K. (2018) · Reproductive Medicine and Biology · doi:10.1002/rmb2.12078 · Cited by 30
Breaking the Glyco-Code of HIV Persistence and Immunopathogenesis
Colomb, F., Giron, L. B., Trbojević‐Akmačić, I., Lauc, G., & Abdel‐Mohsen, M. (2019) · Current HIV/AIDS Reports · doi:10.1007/s11904-019-00433-w · Cited by 29
A recombinant human IgG1 Fc multimer designed to mimic the active fraction of IVIG in autoimmunity
Zhang, X., Owens, J. M., Olsen, H. S., So, E. C., Burch, E. E., McCroskey, M. C., Li, X., Weber, G. L., Bennett, D., Rybin, D. V., et al. (2019) · JCI Insight · doi:10.1172/jci.insight.121905 · Cited by 32
Mesenchymal stem cell alongside exosomes as a novel cell-based therapy for COVID-19: A review study
Dauletova, M., Hafsan, H., Mahhengam, N., Zekiy, A. O., Ahmadi, M., & Siahmansouri, H. (2021) · Clinical Immunology · doi:10.1016/j.clim.2021.108712 · Cited by 29
Detection and functional resolution of soluble immune complexes by an FcγR reporter cell panel
Chen, H., Maul‐Pavicic, A., Holzer, M., Huber, M., Salzer, U., Chevalier, N., Voll, R. E., Hengel, H., & Kolb, P. (2021) · EMBO Molecular Medicine · doi:10.15252/emmm.202114182 · Cited by 29
Herman, J. D., Wang, C., Burke, J. S., Zur, Y., Compere, H., Kang, J., Macvicar, R., Taylor, S., Shin, S. A., Frank, I., et al. (2022) · Cell Reports Medicine · doi:10.1016/j.xcrm.2022.100811 · Cited by 36
Pech, T., Finger, T., Fujishiro, J., Praktiknjo, M., Ohsawa, I., Abu-Elmagd, K. M., Limmer, A., Hirner, A., Kalff, J. C., & Schaefer, N. (2010) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2010.03279.x · Cited by 31
Gordan, S., Biburger, M., & Nimmerjahn, F. (2015) · Immunological Reviews · doi:10.1111/imr.12347 · Cited by 37
Self-citationGuimaraes, A. J., Frasés, S., Pontes, B., de Cerqueira, M. D., Rodrigues, M. L., Viana, N. B., Nimrichter, L., & Nosanchuk, J. D. (2010) · Infection and Immunity · doi:10.1128/iai.00673-10 · Cited by 30
Glyco‐biomarkers: Potential Determinants of Cellular Physiology and Pathology
Alavi, A., & Axford, J. S. (2008) · Disease Markers · doi:10.1155/2008/863032 · Cited by 29
Immunological responses to influenza vaccination: lessons for improving vaccine efficacy
Wang, T. T., Bournazos, S., & Ravetch, J. V. (2018) · Current Opinion in Immunology · doi:10.1016/j.coi.2018.04.026 · Cited by 31
Self-citationParyzhak, S. Y., Dumych, T. I., Mahorivska, I., Boichuk, M. O., Bila, G., Peshkova, S., Nehrych, T. I., & Bilyy, R. O. (2018) · Autoimmunity · doi:10.1080/08916934.2018.1514390 · Cited by 29
Segu, Z. M., Stone, T. A., Berdugo, C., Roberts, A., Doud, E. H., & Li, Y. (2020) · mAbs · doi:10.1080/19420862.2020.1750794 · Cited by 34
Recombinant antibodies for cancer therapy
Deonarain, M. P. (2008) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.8.8.1123 · Cited by 35
IVIG Therapy: Interfering with Interferon-γ
Clynes, R. (2007) · Immunity · doi:10.1016/j.immuni.2007.01.006 · Cited by 29
Glycosylation profiling in clinical proteomics: heading for glycan biomarkers
Wuhrer, M. (2007) · Expert Review of Proteomics · doi:10.1586/14789450.4.2.135 · Cited by 29
Gordon, S., & Plüddemann, A. (2016) · Elsevier eBooks · doi:10.1016/b978-0-323-31696-5.00010-3 · Cited by 29
Glycomics in Human Diseases and Its Emerging Role in Biomarker Discovery
Onigbinde, S. B., Adeniyi, M., Daramola, O. E., Chukwubueze, F. M., Bhuiyan, M. M. A. A., Nwaiwu, J. I., Bhattacharjee, T., & Mechref, Y. S. (2025) · Biomedicines · doi:10.3390/biomedicines13082034 · Cited by 44
Barb, A. W., Ho, T. G., Flanagan‐Steet, H. R., & Prestegard, J. H. (2012) · Protein Science · doi:10.1002/pro.2133 · Cited by 30
Passive Serum Therapy to Immunomodulation by IVIG: A Fascinating Journey of Antibodies
Joao, C. M., Negi, V. S., Kazatchkine, M. D., Bayry, J., & Kaveri, S. V. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1701271 · Cited by 33
Sonneveld, M. E., Koeleman, C. A. M., Plomp, H. R., Wuhrer, M., van der Schoot, C. E., & Vidarsson, G. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00129 · Cited by 30
Giron, L. B., Tanes, C., Schleimann, M. H., Engen, P. A., Mattei, L. M., Anzurez, A., Damra, M., Zhang, H., Bittinger, K. L., Bushman, F. D., et al. (2020) · Mucosal Immunology · doi:10.1038/s41385-020-0279-5 · Cited by 31
Interferon-α alters host glycosylation machinery during treated HIV infection
Giron, L. B., Colomb, F., Papasavvas, E., Azzoni, L., Yin, X., Fair, M. G., Anzurez, A., Damra, M., Mounzer, K., Kostman, J. R., et al. (2020) · EBioMedicine · doi:10.1016/j.ebiom.2020.102945 · Cited by 30
Novel Therapies to Address Unmet Needs in ITP
Mingot‐Castellano, M. E., Bastida, J. M., Caballero‐Navarro, G., Ureña, L. E., González‐López, T. J., González‐Porras, J. R., Butta, N. V., Canaro, M., Jiménez‐Bárcenas, R., Solano, M. D. C. G. D. C., et al. (2022) · Pharmaceuticals · doi:10.3390/ph15070779 · Cited by 30
Costa, A. R., Withers, J., Rodrigues, M. E., McLoughlin, N., Henriques, M., Oliveira, R., Rudd, P. M., & Azeredo, J. (2012) · New Biotechnology · doi:10.1016/j.nbt.2012.12.002 · Cited by 32
Fuchs, S., Feferman, T., Meidler, R., Margalit, R., Sicsic, C., Wang, N., Zhu, K.-Y., Brenner, T., Laub, O., & Souroujon, M. C. (2008) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2007.11.020 · Cited by 28
Kaufman, G., Massoud, A. H., Audusseau, S., Banville-Langelier, A., Wang, Y., Guay, J., Garellek, J. A., Mourad, W. M., Piccirillo, C. A., McCusker, C. T., et al. (2011) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2010.03663.x · Cited by 28
FcγRIIB: a modulator of cell activation and humoral tolerance
Lehmann, B., Schwab, I., Böhm, S., Lux, A., Biburger, M., & Nimmerjahn, F. (2012) · Expert Review of Clinical Immunology · doi:10.1586/eci.12.5 · Cited by 29
Self-citationKonno, N., Sugimoto, M., Takagi, T. J., Furuya, M. Y., Asano, T., Sato, S., Kobayashi, H., Migita, K., Miura, Y., Aihara, T., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0196163 · Cited by 32
Martínez, T. M., García-Robledo, J. E., Plata, I., Urbano, M.-A., Posso‐Osorio, I., Ríos-Serna, L. J., Barrera, M. C., & Tobón, G. J. (2019) · Autoimmunity Reviews · doi:10.1016/j.autrev.2018.10.002 · Cited by 29
Human neutrophil Fc gamma receptors: different buttons for different responses
Alemán, O. R., & Rosales, C. (2023) · Journal of Leukocyte Biology · doi:10.1093/jleuko/qiad080 · Cited by 35
The importance of IgG N-glycosylation in Health, Disease, and Neonatal hemochromatosis
Thaçi, K., & Anthony, R. M. (2025) · Glycoscience & Therapy · doi:10.1016/j.glycos.2025.100002 · Cited by 33
Metadata
- Authors
- Kaneko, Y., Nimmerjahn, F., & Ravetch, J. V.
- Affiliations
- Rockefeller University (US)
- Corresponding author
- Kaneko, Yoshikatsu
- Nimmerjahn, Falk
- Ravetch, Jeffrey V.
- Venue
- Science
- Published
- 2006-08-04
- Volume
- 313
- Issue
- 5787
- Pages
- 670-673
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2035433348
- Cited by
- 1,754
- References
- 21
- Citations by year
- 2026: 45 · 2025: 55 · 2024: 63 · 2023: 67 · 2022: 77 · 2021: 101 · 2020: 103 · 2019: 93 · 2018: 97 · 2017: 89 · 2016: 96 · 2015: 105 · 2014: 122 · 2013: 113 · 2012: 98
- FWCI
- 71.55
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Monoclonal and Polyclonal Antibodies Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Glycosylation and Glycoproteins Research
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Keywords
- IgG, Fc fragment, anti-inflammatory activity, Fc gamma receptor, immune complexes, intravenous immunoglobulin, antigen-specific immune response, innate immunity, adaptive immunity, pro-inflammatory effects
- MeSH terms
- Animals, Antibodies, Monoclonal, Arthritis, Arthritis, Rheumatoid, Glycosylation, Half-Life, Immunoglobulin G, Immunoglobulin Fc Fragments, Inflammation, Mice, Inbred C57BL, Nephritis, Polysaccharides, Receptors, Fc, Sialic Acids, Mice, Inbred NOD, Immunoglobulins, Intravenous, Receptors, IgG, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.